Trials / Completed
CompletedNCT00359008
PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 336 (actual)
- Sponsor
- Notal Vision Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the ability of the PHP \& HPHP to detect newly diagnosed non treated Chorodial neovascularization (CNV) lesion associate with advanced age related Macular Degeneration (AMD) and differentiate them from Early/intermediate/GA AMD
Detailed description
the study is prospective, multi-center, comparative The PHP is a class I FDA approved Device ( K050350 )
Conditions
Timeline
- Start date
- 2006-07-01
- Completion
- 2007-09-01
- First posted
- 2006-08-01
- Last updated
- 2008-01-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00359008. Inclusion in this directory is not an endorsement.